home / stock / phcuf / phcuf short
Short Information | Photocure Asa (OTCMKTS:PHCUF)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 19,218 |
Total Actual Volume | 23,798 |
Short Trends | |
---|---|
Cover Days | 1 |
Short Days | 18 |
No Change Days | 1 |
Averages | |
---|---|
Average Short Volume | 961 |
Average Short Percentage | 93.25% |
Is there a PHCUF Short Squeeze or Breakout about to happen?
See the PHCUF Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
03-04-2024 | $0 | $5.95 | $0 | $0 | 67 | 67 | 100% |
03-01-2024 | $5.95 | $5.95 | $5.95 | $5.95 | 100 | 100 | 100% |
11-11-2022 | $10.13 | $10.13 | $10.13 | $10.13 | 300 | 100 | 33.33% |
01-31-2022 | $10.5 | $10.5 | $10.5 | $10.5 | 2,500 | 2,500 | 100% |
10-04-2021 | $12.25 | $12.25 | $12.25 | $12.25 | 6,300 | 6,300 | 100% |
03-31-2021 | $16 | $16 | $16 | $16 | 100 | 100 | 100% |
03-01-2021 | $14 | $14 | $14 | $14 | 326 | 326 | 100% |
07-01-2020 | $7.6 | $7.6 | $7.6 | $7.6 | 1,000 | 1,000 | 100% |
06-26-2020 | $7.6 | $7.6 | $7.6 | $7.6 | 100 | 100 | 100% |
06-22-2020 | $8.65 | $8.65 | $8.65 | $8.65 | 100 | 100 | 100% |
06-19-2020 | $8.81 | $8.8 | $8.81 | $8.8 | 7,680 | 3,200 | 41.67% |
04-30-2020 | $6.8 | $6.8 | $6.8 | $6.8 | 1,000 | 1,000 | 100% |
04-29-2020 | $7 | $7 | $7 | $7 | 100 | 100 | 100% |
04-17-2020 | $7 | $6.96 | $7 | $6.96 | 1,250 | 1,500 | 120% |
01-03-2020 | $9.80 | $9.80 | $9.80 | $9.80 | 250 | 250 | 100% |
12-23-2019 | $10.15 | $10.15 | $10.15 | $10.15 | 1,800 | 1,800 | 100% |
12-13-2019 | $9.29 | $9.18 | $9.29 | $9.18 | 500 | 350 | 70% |
12-06-2019 | $N/A | $11.12 | $N/A | $N/A | 25 | 25 | 100% |
12-04-2019 | $11.12 | $11.12 | $11.12 | $11.12 | 100 | 100 | 100% |
11-22-2019 | $6.96 | $6.96 | $6.96 | $6.96 | 200 | 200 | 100% |
News, Short Squeeze, Breakout and More Instantly...
Photocure Asa Company Name:
PHCUF Stock Symbol:
OTCMKTS Market:
Photocure Partner Asieris Announces Completion of Patient Enrollment in Cevira Phase III Clinical Trial PR Newswire OSLO, Norway , Aug. 9, 2022 /PRNewswire/ -- On August 9, 2022 , Asieris Pharmaceuticals, a global biopharmaceutical company specializ...
Photocure ASA: Results for the first quarter of 2022 PR Newswire OSLO, Norway , May 11, 2022 /PRNewswire/ -- Photocure ASA (OSE: PHO) today reported Hexvix ® /Cysview ® revenues of NOK 81.4 million in the first quarter of 2022 (Q1 ...
Photocure Partner Asieris announces CDE Approval for Hexvix Clinical Real-World Evidence Study in China PR Newswire OSLO, Norway , March 11, 2022 /PRNewswire/ -- Photocure ASA ( PHO: OSE), The Bladder Cancer Company, announces that its partner Asieris Pharm...